{"component": "definition", "props": {"groups": [{"samples": [{"hash": "aNyA2lEIEiw", "uri": "https://www.tuev-nord.de/fileadmin/Content/TUEV_NORD_DE/zertifizierung/TUV_NORD_MDR_BUCH_EN.pdf", "label": "www.tuev-nord.de", "score": 19.0479793549, "published": false}, {"hash": "7TwkNkesdJK", "uri": "https://www.tuv-nord.com/fileadmin/user_upload/TUEV_NORD_MDR_including_M3.pdf", "label": "www.tuv-nord.com", "score": 18.8633995056, "published": false}, {"hash": "gIanjEF2Lfa", "uri": "https://www.parlament.gv.at/dokument/XXV/EU/135463/imfname_10701541.pdf", "label": "www.parlament.gv.at", "score": 12.0650892258, "published": false}], "snippet_links": [{"key": "adverse-event", "type": "definition", "offset": [10, 23]}], "snippet": "means any adverse event that led to any of the following:", "size": 101, "hash": "0e019341a90c6c2a164a84778b380888", "id": 1}, {"samples": [{"hash": "4x1RfIAbBpt", "uri": "/contracts/4x1RfIAbBpt#serious-adverse-event", "label": "Clinical Investigation Research Agreement", "score": 36.4757080078, "published": true}, {"hash": "5GkMBLkzgTp", "uri": "/contracts/5GkMBLkzgTp#serious-adverse-event", "label": "Clinical Trial Research Agreement", "score": 36.0219306946, "published": true}, {"hash": "1i5JUmaXqFb", "uri": "/contracts/1i5JUmaXqFb#serious-adverse-event", "label": "Clinical Investigation Research Agreement", "score": 34.7751998901, "published": true}], "snippet_links": [{"key": "access-to", "type": "definition", "offset": [43, 52]}, {"key": "clinical-trials", "type": "definition", "offset": [84, 99]}], "snippet": "has the meaning given in the TGA document \u201cAccess to Unapproved Therapeutic Goods \u2013 Clinical Trials in Australia\u201d (October 2004) or its replacement.", "size": 85, "hash": "ffec7cfe88b6a1835b093ef05a63d2fe", "id": 2}, {"samples": [{"hash": "5RCGnxzlyqp", "uri": "https://www.legis.iowa.gov/docs/ACO/GNAC/iacpdf(3-1-06)/iac/641iac/64141/64141.pdf", "label": "www.legis.iowa.gov", "score": 16.7170162201, "published": false}, {"hash": "3QTK9nkpgSt", "uri": "https://www.legis.iowa.gov/docs/aco/arc/6051C.rtf", "label": "Notice", "score": 15.1204652786, "published": false}, {"hash": "BeVDRMeNLy", "uri": "https://www.legis.iowa.gov/docs/aco/arc/6051C.pdf", "label": "Notice", "score": 14.9370298386, "published": false}], "snippet_links": [{"key": "adverse-event", "type": "definition", "offset": [9, 22]}, {"key": "a-facility", "type": "definition", "offset": [105, 115]}, {"key": "appropriate-corrective-action", "type": "clause", "offset": [130, 159]}, {"key": "in-a-timely-manner", "type": "definition", "offset": [160, 178]}], "snippet": "means an adverse event that may significantly compromise clinical outcomes or an adverse event for which a facility fails to take appropriate corrective action in a timely manner.", "size": 48, "hash": "07b042c1738d3c6d30bf6dc0196bf13c", "id": 3}, {"samples": [{"hash": "8WEy9hfpyuX", "uri": "/contracts/8WEy9hfpyuX#serious-adverse-event", "label": "Collaboration Agreement (Coherus BioSciences, Inc.)", "score": 35.2012329102, "published": true}, {"hash": "2EBqt9kjMRx", "uri": "/contracts/2EBqt9kjMRx#serious-adverse-event", "label": "License Agreement (TradeUP Acquisition Corp.)", "score": 34.4538002014, "published": true}, {"hash": "bHIgQrilAQ2", "uri": "/contracts/bHIgQrilAQ2#serious-adverse-event", "label": "Exclusive, Global   Development, Supply, Marketing & License Agreement (NRX Pharmaceuticals, Inc.)", "score": 34.4236831665, "published": true}], "snippet_links": [{"key": "adverse-drug-experience", "type": "definition", "offset": [9, 32]}, {"key": "threatening-condition", "type": "clause", "offset": [115, 136]}, {"key": "inpatient-hospitalization", "type": "clause", "offset": [142, 167]}, {"key": "persistent-or-significant-disability-or-incapacity", "type": "definition", "offset": [231, 281]}, {"key": "substantial-disruption", "type": "definition", "offset": [285, 307]}, {"key": "ability-to", "type": "definition", "offset": [315, 325]}, {"key": "congenital-anomaly", "type": "definition", "offset": [366, 384]}, {"key": "birth-defect", "type": "definition", "offset": [385, 397]}, {"key": "permanent-impairment", "type": "definition", "offset": [450, 470]}], "snippet": "means an adverse drug experience or circumstance that results in any of the following outcomes (a) death, (b) life-threatening condition, (c) inpatient hospitalization or a significant prolongation of existing hospitalization, (d) persistent or significant disability or incapacity or substantial disruption of the ability to conduct normal life functions, (e) or a congenital anomaly/birth defect or (f) significant intervention required to prevent permanent impairment or damage.", "size": 48, "hash": "2e127173731154b1decd62efa74a19d8", "id": 4}, {"samples": [{"hash": "dg6Y6E2Iyzv", "uri": "/contracts/dg6Y6E2Iyzv#serious-adverse-event", "label": "License Agreement (Tg Therapeutics, Inc.)", "score": 29.1998634338, "published": true}, {"hash": "efUFBo7OWov", "uri": "/contracts/efUFBo7OWov#serious-adverse-event", "label": "License Agreement (Checkpoint Therapeutics, Inc.)", "score": 27.5242977142, "published": true}, {"hash": "4rdoTKrjKqu", "uri": "/contracts/4rdoTKrjKqu#serious-adverse-event", "label": "License Agreement (Checkpoint Therapeutics, Inc.)", "score": 27.2258720398, "published": true}], "snippet_links": [{"key": "inpatient-hospitalization", "type": "clause", "offset": [105, 130]}, {"key": "significant-disability", "type": "definition", "offset": [201, 223]}, {"key": "congenital-anomaly", "type": "definition", "offset": [244, 262]}, {"key": "birth-defect", "type": "definition", "offset": [263, 275]}], "snippet": "means any untoward medical occurrence that, at any dose, results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, or is a congenital anomaly/birth defect, as more full defined in 21 CFR \u00a7 312.32.", "size": 44, "hash": "6245a710c8ed95531b40dfb6665a3d1a", "id": 5}, {"samples": [{"hash": "k3P0qDqned1", "uri": "/contracts/k3P0qDqned1#serious-adverse-event", "label": "Clinical Trial Activities Agreement", "score": 26.106092453, "published": true}, {"hash": "7y4MFQ3lgGQ", "uri": "/contracts/7y4MFQ3lgGQ#serious-adverse-event", "label": "Licence Agreement (Senetek PLC /Eng/)", "score": 21.0, "published": true}, {"hash": "cN0YylHXIkC", "uri": "https://www.ogtr.gov.au/sites/default/files/2022-09/dir192_licence_conditions.pdf", "label": "www.ogtr.gov.au", "score": 11.3572893143, "published": false}], "snippet_links": [], "snippet": "means any untoward medical occurrence that at any dose:", "size": 29, "hash": "9729be12918e89ad231f49e9a70e6446", "id": 6}, {"samples": [{"hash": "gYT2q5zuTvd", "uri": "/contracts/gYT2q5zuTvd#serious-adverse-event", "label": "Distribution Agreement (Molecular Pharmacology (USA) LTD)", "score": 21.0, "published": true}, {"hash": "68XzqyO67vA", "uri": "/contracts/68XzqyO67vA#serious-adverse-event", "label": "Distribution Agreement (Molecular Pharmacology (USA) LTD)", "score": 21.0, "published": true}, {"hash": "2FDI76TsBD7", "uri": "/contracts/2FDI76TsBD7#serious-adverse-event", "label": "Asset Purchase and Sale Agreement (Prometheus Laboratories Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "inpatient-hospitalization", "type": "clause", "offset": [133, 158]}, {"key": "significant-disability", "type": "definition", "offset": [220, 242]}, {"key": "congenital-anomaly", "type": "definition", "offset": [260, 278]}, {"key": "birth-defect", "type": "definition", "offset": [279, 291]}, {"key": "events-that", "type": "clause", "offset": [311, 322]}, {"key": "event-when", "type": "clause", "offset": [432, 442]}, {"key": "medical-judgment", "type": "clause", "offset": [467, 483]}], "snippet": "means an Adverse Event occurring at any dose that results in any of the following outcomes: death, a life-threatening Adverse Event, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a Serious Adverse Event when, based upon appropriate medical judgment, they may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition.", "size": 18, "hash": "c1d1e95a1dbea9570fc88eff7d133cbb", "id": 7}, {"samples": [{"hash": "bT28Q9D3o7e", "uri": "/contracts/bT28Q9D3o7e#serious-adverse-event", "label": "Clinical Collaboration and Supply Agreement (Olema Pharmaceuticals, Inc.)", "score": 34.3497619629, "published": true}, {"hash": "eyYavEt1ox5", "uri": "/contracts/eyYavEt1ox5#serious-adverse-event", "label": "Clinical Trial Collaboration and Supply Agreement (Aveo Pharmaceuticals, Inc.)", "score": 32.3538665771, "published": true}, {"hash": "7bscJeqp7il", "uri": "/contracts/7bscJeqp7il#serious-adverse-event", "label": "Master Clinical Trial Collaboration Agreement (Checkmate Pharmaceuticals, Inc.)", "score": 32.2388763428, "published": true}], "snippet_links": [{"key": "serious-adverse-drug-reaction", "type": "definition", "offset": [13, 42]}, {"key": "the-meanings", "type": "definition", "offset": [64, 76]}, {"key": "data-management", "type": "definition", "offset": [199, 214]}, {"key": "definitions-and-standards", "type": "clause", "offset": [221, 246]}, {"key": "expedited-reporting", "type": "clause", "offset": [251, 270]}], "snippet": "(\u201cSAE\u201d) and \u201cSerious Adverse Drug Reaction\u201d (\u201cSADR\u201d) shall have the meanings provided to such terms in the International Conference on Harmonization (\u201cICH\u201d) guideline for industry on Clinical Safety Data Management (E2A, Definitions and Standards for Expedited Reporting).", "size": 17, "hash": "0e6aad3ae449029b993e4017606e51e1", "id": 8}, {"samples": [{"hash": "cDCUHmA64vX", "uri": "/contracts/cDCUHmA64vX#serious-adverse-event", "label": "Confidentiality Agreement (Esperion Therapeutics, Inc.)", "score": 32.5865859985, "published": true}, {"hash": "3gKXIRn9bgE", "uri": "/contracts/3gKXIRn9bgE#serious-adverse-event", "label": "License and Collaboration Agreement (Esperion Therapeutics, Inc.)", "score": 31.6064338684, "published": true}, {"hash": "aRqYqJAnHiu", "uri": "/contracts/aRqYqJAnHiu#serious-adverse-event", "label": "Research Services, License and Collaboration Agreement (Repare Therapeutics Inc.)", "score": 31.4065704346, "published": true}], "snippet_links": [{"key": "adverse-drug-experience", "type": "definition", "offset": [9, 32]}, {"key": "inpatient-hospitalization", "type": "clause", "offset": [138, 163]}, {"key": "persistent-or-significant-disability-or-incapacity", "type": "definition", "offset": [213, 263]}, {"key": "substantial-disruption", "type": "definition", "offset": [267, 289]}, {"key": "ability-to", "type": "definition", "offset": [297, 307]}, {"key": "congenital-anomaly", "type": "definition", "offset": [345, 363]}, {"key": "birth-defect", "type": "definition", "offset": [364, 376]}, {"key": "permanent-impairment", "type": "definition", "offset": [427, 447]}, {"key": "medical-event", "type": "definition", "offset": [467, 480]}, {"key": "based-on", "type": "definition", "offset": [563, 571]}, {"key": "medical-judgment", "type": "clause", "offset": [584, 600]}, {"key": "in-clauses", "type": "clause", "offset": [735, 745]}], "snippet": "means an adverse drug experience or circumstance that results in any of the following outcomes (a) death, (b) life-threatening event, (c) inpatient hospitalization or prolongation of existing hospitalization, (d) persistent or significant disability or incapacity or substantial disruption of the ability to conduct normal life functions, (e) a congenital anomaly/birth defect, (f) significant intervention required to prevent permanent impairment or damage or (g) a medical event that may not result in death, be life-threatening or require hospitalization but, based on appropriate medical judgment, that may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes described in clauses (a) through (e).", "size": 17, "hash": "8e8e2de0274b6bf1b902f3e46c624c60", "id": 9}, {"samples": [{"hash": "6B3pXd1vHA9", "uri": "/contracts/6B3pXd1vHA9#serious-adverse-event", "label": "Product Know How License Agreement", "score": 29.3408622742, "published": true}, {"hash": "gE5MFuZRfV1", "uri": "/contracts/gE5MFuZRfV1#serious-adverse-event", "label": "Partnership Agreement (Bristol Myers Squibb Co)", "score": 21.0, "published": true}, {"hash": "7yjs4arE7o1", "uri": "/contracts/7yjs4arE7o1#serious-adverse-event", "label": "Alliance Support Agreement (Bristol Myers Squibb Co)", "score": 21.0, "published": true}], "snippet_links": [{"key": "adverse-event", "type": "definition", "offset": [10, 23]}, {"key": "at-risk", "type": "definition", "offset": [95, 102]}, {"key": "permanent-disability", "type": "definition", "offset": [187, 207]}, {"key": "birth-defect", "type": "definition", "offset": [209, 221]}], "snippet": "means any Adverse Event that is life-threatening in that such Adverse Event places the patient at risk of dying, requires hospitalization, prolongs existing hospitalization or results in permanent disability, birth defect, cancer or death.", "size": 17, "hash": "f98c4309d2a69d2f98ff814965308507", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIec2VyaW91cy1hZHZlcnNlLWV2ZW50IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means any adverse event that led to any of the following:", "size": 929, "title": "Serious Adverse Event", "id": "serious-adverse-event", "examples": ["A <strong>Serious Adverse Event</strong> (SAE) is any event (whether or not associated with the investigational device) that: \u2022 Results in death \u2022 Leads to serious deterioration in the health of the subject, that either resulted in \u2022 Life threatening illness or injury, or \u2022 Permanent impairment of a body structure or a body function, or \u2022 In-subject or prolonged hospitalization, or \u2022 Medical or surgical intervention to prevent life threatening illness or injury or permanent impairment to a body structure or body function."], "related": [["material-adverse-event", "Material Adverse Event", "Material Adverse Event"], ["adverse-event", "Adverse Event", "Adverse Event"], ["company-material-adverse-change", "Company Material Adverse Change", "Company Material Adverse Change"], ["company-material-adverse-effect", "Company Material Adverse Effect", "Company Material Adverse Effect"], ["serious", "Serious", "Serious"]], "related_snippets": [], "updated": "2026-08-08T05:41:39+00:00"}, "json": true, "cursor": ""}}